503 related articles for article (PubMed ID: 19614764)
1. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of cyclin B1 in non-small cell lung cancer.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Kimura Y; Uchida Y
Oncol Rep; 2003; 10(5):1381-6. PubMed ID: 12883711
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
Soria JC; Jang SJ; Khuri FR; Hassan K; Liu D; Hong WK; Mao L
Cancer Res; 2000 Aug; 60(15):4000-4. PubMed ID: 10945597
[TBL] [Abstract][Full Text] [Related]
4. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
6. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
[TBL] [Abstract][Full Text] [Related]
7. [The evaluation of prognostic value of cyclin B1 expression in patients with resected non-small-cell lung cancer stage I-IIIA--preliminary report].
Kosacka M; Korzeniewska A; Jankowska R
Pol Merkur Lekarski; 2010 Feb; 28(164):117-21. PubMed ID: 20369739
[TBL] [Abstract][Full Text] [Related]
8. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
11. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.
Hansen LV; Skov BG; Ploug M; Pappot H
Lung Cancer; 2007 Nov; 58(2):260-6. PubMed ID: 17706320
[TBL] [Abstract][Full Text] [Related]
12. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
Yuan K; Qian C; Zheng R
Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048
[TBL] [Abstract][Full Text] [Related]
14. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
Zhang Z; Ma J; Li N; Sun N; Wang C
Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
[TBL] [Abstract][Full Text] [Related]
15. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327
[TBL] [Abstract][Full Text] [Related]
16. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
18. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
[TBL] [Abstract][Full Text] [Related]
19. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S
Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
[TBL] [Abstract][Full Text] [Related]
20. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
